Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Drug Delivery

News in brief

West and Amgen sign Crystal Zenith evaluation deal

Last updated on 21-Jun-2012 at 09:52 GMT

West Pharmaceutical Services has inked a deal with Amgen to evaluate its Crystal Zenith technology for drug containment.

Crystal Zenith was developed by Daikyo Seiko, a partner of West, to avoid problems associated with using glass vials. Amgen encountered these shortcomings in 2010 when a recall of vials containing glass flakes cost it tens of millions of dollars.

Biopharmaceutical therapeutic products require a drug container that enables safe, effective and reliable containment,” Donald Morel, CEO of West, said. Amgen and West have a long-standing relationship and the Crystal Zenith deal builds on their earlier business dealings.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Key Industry Events


Access all events listing

Our events, Events from partners...